Registered entities
GLOBEIMMUNE INC
Reg. No. 1245104United States
Globeimmune, Inc.
Reg. No. 841353925United States
Innovation
40 patent families (28 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing, Electricity & electronics; filing pace slowing. Cited 9,001 times.
| Year | Filings |
|---|---|
| 2014 | 17 |
| 2015 | 17 |
| 2016 | 15 |
| 2017 | 11 |
| 2018 | 13 |
| 2019 | 10 |
| 2020 | 11 |
| 2021 | 13 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 2 |
Investor mix
21 investors on record; lead investors include EFG Bank, Wexford Capital, Celgene.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 33% |
| Private equity | 3 | 14% |
| Other / undisclosed | 11 | 52% |